• Preventive Mastectomies Provide Little Survival Benefit for Ovarian Cancer Patients, Study Finds
  • Cancer Protein CA125 Blocks Investigational Therapy Farletuzumab’s Anti-Tumor Effectiveness, Study Finds
  • FDA Expands Use of DigniCap to Prevent Chemotherapy-induced Hair Loss
  • BRCA1 and BRCA2 Mutations Increase Risk for Breast, Ovarian Cancers, Study Finds
  • Celsion’s GEN-1 Combined with Chemotherapy May Help Treat Advanced Ovarian Cancer
  • Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer
  • Half of Ovarian Cancer Patients Respond to Quisinostat Combo Therapy, Phase 2 Clinical Trial Shows
  • Actress Fran Drescher Headlines Tina’s Wish NYC Ovarian Cancer Fundraising Event
  • PharmaMar’s Lurbinectedin to Be Marketed as Zepsyre After Approval as Ovarian Cancer Therapy
  • Clovis to Apply for Expanded FDA Approval for Rubraca in Ovarian Cancer Patients
  • CARMA Advances Funding for Development of Immunotherapy Program to Treat Metastatic Solid Tumors
  • Geisinger Health System Hits Milestone with 150,000 Participants in Biobank and DNA Sequencing Study